Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Damm

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Genes, Chromosomes & Cancer|June 6, 2014
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patternsFrederik Damm, Birgit Markus, Felicitas Thol, et al.
Leukemia|July 3, 2021
Clonal hematopoiesis and its emerging effects on cellular therapiesMalte von Bonin, Helena Klara Jambor, Raphael Teipel, et al.
Haematologica|January 19, 2011
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotypeKatharina Wagner, Frederik Damm, Felicitas Thol, et al.
Leukemia|November 16, 2021
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9Friederike Christen, Raphael Hablesreiter, Kaja Hoyer, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 3, 2024
Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical applicationMoritz V Scharr, Frederik Damm, Paul Krahl, et al.
Annals of Hematology|April 17, 2014
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemiaChristoph W M Reuter, Jürgen Krauter, Fredrick O Onono, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Annals of Hematology|December 13, 2012
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemiaFelicitas Thol, Claudia Winschel, Ann-Kathrin Sonntag, et al.
Haematologica|June 5, 2014
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemiaHaiyang Yun, Frederik Damm, Damian Yap, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Genes, Chromosomes & Cancer|June 6, 2014
TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patternsFrederik Damm, Birgit Markus, Felicitas Thol, et al.
Leukemia|July 3, 2021
Clonal hematopoiesis and its emerging effects on cellular therapiesMalte von Bonin, Helena Klara Jambor, Raphael Teipel, et al.
Haematologica|January 19, 2011
FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotypeKatharina Wagner, Frederik Damm, Felicitas Thol, et al.
Leukemia|November 16, 2021
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9Friederike Christen, Raphael Hablesreiter, Kaja Hoyer, et al.
British Journal of Haematology|May 10, 2012
ID1 expression associates with other molecular markers and is not an independent prognostic factor in cytogenetically normal acute myeloid leukaemiaFrederik Damm, Katharina Wagner, Kerstin Görlich, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 3, 2024
Review of preclinical data on hyperthermia treatment in lymphomas and its potential for clinical applicationMoritz V Scharr, Frederik Damm, Paul Krahl, et al.
Annals of Hematology|April 17, 2014
Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemiaChristoph W M Reuter, Jürgen Krauter, Fredrick O Onono, et al.
Genes, Chromosomes & Cancer|March 29, 2012
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutationsFelicitas Thol, Britta Kölking, Frederik Damm, et al.
Annals of Hematology|December 13, 2012
Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemiaFelicitas Thol, Claudia Winschel, Ann-Kathrin Sonntag, et al.
Haematologica|June 5, 2014
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemiaHaiyang Yun, Frederik Damm, Damian Yap, et al.
Pageof 7